Orlistat reduces features of the metabolic syndrome: the XENDOS study

Diabetes Obes Metab. 2003 Sep;5(5):356.
No abstract available

Publication types

  • News

MeSH terms

  • Anti-Obesity Agents / therapeutic use*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Humans
  • Lactones / therapeutic use*
  • Metabolic Syndrome / drug therapy*
  • Orlistat

Substances

  • Anti-Obesity Agents
  • Lactones
  • Orlistat